(Q46194079)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19090012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Phase 1 and pharmacokinetic study of concurrent carboplatin and irinotecan in subjects aged 1 to 21 years with refractory solid tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19090012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19090012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Richard G Gorlick

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19090012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

3

Leonard H Wexler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19090012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Adam S Levy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19090012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Regina Jakacki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19090012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Anne Angiolillo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19090012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sarah N Ringuette

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19090012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Marvin B Cohen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19090012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19090012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19090012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19090012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19090012%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

207-216

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19090012%20AND%20SRC:MED&resulttype=core&format=json

The current status of camptothecin analogues as antitumor agents

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

Effects of CPT-11 in combination with other anti-cancer agents in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

Carboplatin and recurrent childhood brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

Carboplatin for the treatment of children with newly diagnosed optic chiasm gliomas: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

A phase I study and pharmacologic evaluation of irinotecan and carboplatin for patients with advanced ovarian carcinoma who previously received platinum-containing chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

Phase II study of irinotecan combined with carboplatin in previously untreated small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

Irinotecan for pediatric solid tumors: the Memorial Sloan-Kettering experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

Phase II study of a protracted irinotecan schedule in children with refractory or recurrent soft tissue sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

Phase I Study and Pharmacokinetics of CPT-11 With 5-Day Continuous Infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

Topoisomerase I inhibitors. An overview of the camptothecin analogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

7 January 2021

New natural products in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

7 January 2021

Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

7 January 2021

Phase I and pharmacokinetic trial of weekly CPT-11

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

7 January 2021

Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

7 January 2021

Combination phase I/II study of irinotecan hydrochloride (CPT-11) and carboplatin in relapsed or refractory non-Hodgkin's lymphoma. CPT-11/Lymphoma Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23992

7 January 2021